DCGI approves anti-Covid drug developed by DRDO for emergency use

India Today 2021-05-08

Views 9

In partnership with Dr Reddy's Laboratories in Hyderabad, the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of the Defence Research and Development Organisation (DRDO), has developed an anti-Covid-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG).

Share This Video


Download

  
Report form
RELATED VIDEOS